Hepatic passaging of NRAS-mutant melanoma influences adhesive properties and metastatic pattern
Abstract Background Liver metastasis is a poor prognostic factor for treatment of advanced cutaneous melanoma with either immunotherapy or targeted therapies. In this study we focused on NRAS mutated melanoma, a cohort with high unmet clinical need. Methods WT31 melanoma was repeatedly passaged over...
Main Authors: | Bianca Dietsch, Céline Weller, Carsten Sticht, Carolina de la Torre, Martin Kramer, Sergij Goerdt, Cyrill Géraud, Sebastian A. Wohlfeil |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-023-10912-4 |
Similar Items
-
Deficiency of Stabilin-1 in the Context of Hepatic Melanoma Metastasis
by: Sebastian A. Wohlfeil, et al.
Published: (2024-01-01) -
Angiogenic and molecular diversity determine hepatic melanoma metastasis and response to anti-angiogenic treatment
by: Sebastian A. Wohlfeil, et al.
Published: (2022-02-01) -
Melanoma ganglionic metastasis 30 years after treatment of the primary tumor: a case report
by: Alfio José Tincani, et al. -
Dynamic and unpredictable changes in mutant allele fractions of BRAF and NRAS during visceral progression of cutaneous malignant melanoma
by: V. Doma, et al.
Published: (2019-08-01) -
Chromatin state profiling reveals PRC2 inhibition as a therapeutic target in NRAS–mutant melanoma
by: Christopher J. Terranova
Published: (2021-09-01)